These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22296585)

  • 1. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies.
    Cataland SR; Yang S; Wu HM
    Br J Haematol; 2012 May; 157(4):501-3. PubMed ID: 22296585
    [No Abstract]   [Full Text] [Related]  

  • 2. Absolute immature platelet count helps differentiate thrombotic thrombocytopenic purpura from hypertension-induced thrombotic microangiopathy.
    Zheng Y; Hong H; Reeves HM; Maitta RW
    Transfus Apher Sci; 2014 Aug; 51(1):54-7. PubMed ID: 25130726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of 'real-time' complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies.
    Prohászka Z; Varga L; Füst G
    Br J Haematol; 2012 Aug; 158(3):424-5. PubMed ID: 22612063
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.
    Hassan S; Westwood JP; Ellis D; Laing C; Mc Guckin S; Benjamin S; Scully M
    Br J Haematol; 2015 Dec; 171(5):830-5. PubMed ID: 26359646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 deficiency in severe postpartum HELLP syndrome.
    Pourrat O; Coudroy R; Pierre F
    Br J Haematol; 2013 Nov; 163(3):409-10. PubMed ID: 23889130
    [No Abstract]   [Full Text] [Related]  

  • 8. Methodologies and clinical utility of ADAMTS-13 activity testing.
    Just S
    Semin Thromb Hemost; 2010 Feb; 36(1):82-90. PubMed ID: 20391299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion medicine illustrated. Massive hemolysis due to thrombotic thrombocytopenic purpura in a patient with AIDS.
    Adamski J; Marques MB
    Transfusion; 2012 Jul; 52(7):1408-9. PubMed ID: 22780894
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical observation of a patient with thrombotic thrombocytopenic purpura with renal and intestinal lesions].
    Stolyar AG; Avdonin PV; Valamina IE; Stolyarevich ES
    Ter Arkh; 2019 Jul; 91(7):106-110. PubMed ID: 32598743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
    Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
    Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura.
    Muia J; Gao W; Haberichter SL; Dolatshahi L; Zhu J; Westfield LA; Covill SC; Friedman KD; Sadler JE
    J Thromb Haemost; 2013 Aug; 11(8):1511-8. PubMed ID: 23773695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13.
    Lansigan F; Isufi I; Tagoe CE
    Rheumatology (Oxford); 2011 May; 50(5):824-9. PubMed ID: 21149242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New marker in thrombotic thrombocytopenic purpura].
    Gøtze JP; Hillarp A; Lindblom A; Björk P; Strandberg K; Nielsen LB
    Ugeskr Laeger; 2008 Aug; 170(33):2446-9. PubMed ID: 18761827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of ADAMTS-13 testing in suspected thrombotic microangiopathy: an audit of ADAMTS-13 activity assay requests in routine practice from a tertiary hospital.
    Garizio DG; Wilgen U; Williams BA; Kennedy GA
    Pathology; 2012 Dec; 44(7):638-41. PubMed ID: 23089737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary thrombotic purpura.
    Khan MR; Ashraf MS
    J Pak Med Assoc; 2014 Feb; 64(2):217-9. PubMed ID: 24640819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immature platelet fraction can help adjust therapy in refractory thrombotic microangiopathic hemolytic anemia cases.
    Kier YE; Stempak LM; Maitta RW
    Transfus Apher Sci; 2013 Dec; 49(3):644-6. PubMed ID: 23899959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the FRETS-vWF73 assay in the patients with thrombotic thrombocytopenic purpura (TTP)].
    Hu LP; Su J; Han Y
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):761-2. PubMed ID: 23336235
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid determination of ADAMTS13 activity improves clinical decision-making.
    Cataland SR; Jin M; Wu HM
    Am J Hematol; 2007 Mar; 82(3):251. PubMed ID: 16929541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.